- Scientists find a dangerous cycle that worsens sepsis
- Could help millions at risk of organ failure
- Still in labs — not yet for patients
This discovery could change how we stop sepsis before it kills.
It starts with a fever. A cough. A small infection. Then, within hours, the body turns on itself.
Sepsis is not just a bad infection. It’s the body’s own defense system going into overdrive. This chaos can shut down organs and kill in days — or even hours.
Millions get sepsis every year. Many survive. But too many don’t. It’s one of the top causes of death in hospitals worldwide.
Current treatments? IV fluids, antibiotics, and time. But sometimes, that’s not enough. The real enemy isn’t just the infection — it’s the body’s response.
Doctors have long searched for a way to calm the storm. Now, scientists may have found the engine behind it.
The Surprising Shift
For years, doctors thought sepsis was mostly about germs running wild. The fix? Kill the bugs fast.
But here’s the twist: the real damage often comes after the infection is gone. The immune system keeps raging — like a fire with no way to stop.
New research points to a hidden loop — a vicious cycle between immune cells and blood platelets. And it may be the main driver of organ failure in sepsis.
Here’s How the Loop Works
Imagine a city under attack. Neutrophils — the body’s first responders — rush in to fight. They release a protein called S100A8/A9 to sound the alarm.
But in sepsis, this alarm gets stuck on repeat. That constant signal pushes neutrophils to die in a violent way — a process called NETosis.
During NETosis, neutrophils explode, throwing out web-like traps (called NETs) to catch germs. But these webs don’t just trap bacteria — they also damage blood vessels and organs.
Worse, those NETs trigger platelets to activate. And activated platelets? They boost more S100A8/A9.
Now the cycle spins faster: S100A8/A9 → NETosis → platelets → more S100A8/A9 → more NETosis.
It’s like a stuck accelerator in the immune system.
What Scientists Didn’t Expect
This loop doesn’t just cause inflammation. It also flips the immune system into paralysis.
Early on, the body is too active — attacking everything, including itself. But later, it becomes too weak to fight anything.
The same loop that starts the fire also burns out the immune system. It drives immune cells like dendritic cells and myeloid-derived suppressor cells into a shutdown mode.
So patients get hit twice: first by storm, then by silence.
This isn’t a clinical trial with patients. It’s a deep analysis of past research — a review that pieces together clues from animal and lab studies.
Scientists mapped how the S100A8/A9–NETosis loop works across cell types. They focused on interactions between white blood cells, platelets, and organ damage.
The goal? To build the first full picture of this cycle in sepsis.
The data suggest this loop is central to sepsis — not just a side effect. It fuels organ injury in the lungs, kidneys, and liver.
In mouse models, blocking S100A8/A9 reduced NETosis and organ damage. Animals lived longer and had less inflammation.
One study showed survival jumped from 20% to over 60% when the loop was interrupted. That’s not a cure — but it’s a powerful signal.
Sepsis isn’t one problem. It’s a chain reaction. And this loop may be the first link that keeps the whole thing going.
This doesn’t mean this treatment is available yet.
But There’s a Catch
That’s not the full story.
The loop doesn’t act alone. It talks to other immune cells — like monocytes and macrophages — and changes their behavior.
Some turn into “clean-up” mode too early, while others stay angry too long. This imbalance makes recovery harder.
Even more concerning: the loop may explain why some sepsis survivors stay weak for months. Their immune systems never fully reset.
Researchers now see sepsis not as a single event — but as a cascade. And this feedback loop could be the control center.
“This may be the missing piece in understanding why some patients crash so fast,” one expert noted. Targeting this loop could help both early and late stages of sepsis.
It’s not just about stopping the fire. It’s about preventing the system from burning out.
If you or a loved one faces sepsis, this research won’t change your care today. No drug targeting this loop is approved yet.
But it’s a roadmap for the future. Doctors may one day test for S100A8/A9 levels to predict who’s at highest risk.
And new drugs could one day break the cycle — before organs fail. For now, fast treatment with antibiotics and fluids remains the best defense.
Talk to your doctor about sepsis signs: confusion, fast breathing, low blood pressure, fever or cold skin. Early action saves lives.
Most of this evidence comes from mice and lab dishes. Human biology can differ.
Also, sepsis varies widely — from pneumonia to UTIs to post-surgery infections. This loop may not drive all types the same way.
More research is needed to confirm if blocking it helps people — not just animals.
Scientists are now testing drugs that block S100A8/A9 or NETosis in animals. If safe, early human trials could start in the next few years.
But even if all goes well, it may take a decade to bring a new treatment to hospitals. Sepsis research is hard — but this new focus could speed things up. For the first time, we may be targeting the engine — not just the smoke.